WP
NUVB icon

Woodline Partners’s Nuvation Bio NUVB Stock Holding History

Woodline Partners’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.54M Buy
975,532
+15,118
+2% +$73.9K 0.02% 674
2026
Q1 		$4.12M Buy
960,414
+2,500
+0.3% +$13.9K 0.02% 693
2025
Q4 		$8.58M Buy
957,914
+2,500
+0.3% +$15.5K 0.03% 498
2025
Q3 		$3.54M Buy
+955,414
New +$2.6M 0.02% 636

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Woodline Partners's NUVB Position: Q2 2026 in Review

Woodline Partners increased its Nuvation Bio (NUVB) stake by 1.6% in Q2 2026, buying an estimated $73.9K and bringing the position to 975,532 shares worth $5.54M. The position accounts for 0.02% of the portfolio, ranked #674.

Woodline Partners first reported a position in NUVB in Q3 2025 and has held it in 4 quarters since. The position peaked at $8.58M in Q4 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Woodline Partners held 975,532 shares of Nuvation Bio worth $5.54M as of Q2 2026.
  • Woodline Partners bought 15,118 Nuvation Bio shares in Q2 2026, an estimated $73.9K.
  • Nuvation Bio made up 0.02% of Woodline Partners's portfolio in Q2 2026, its #674 holding.
  • Woodline Partners first reported a position in Nuvation Bio in Q3 2025 and has held it in 4 quarters since.
  • Woodline Partners's Nuvation Bio position peaked at $8.58M in Q4 2025.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.